πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7879801

Compositions comprising cell-impermeant duramycin derivatives

The Board of Regents of the University of Texas System Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7875276

Urinary tract tissue graft compositions and methods for producing same

The Board of Regents of the University of Oklahoma Β· Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7871775

Compositions and methods for the identification, assessment, prevention and therapy of hum

The Board of Regents of the University of Texas System Β· Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7863414

Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

The Board of Regents of the University of Texas System Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7863275

Uses of tetrahydrobiopterin and derivatives thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7858657

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

Arizona Board of Regents, Acting on Behalf of the University of Arizona Β· Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7858592

Interfering RNAs against the promoter region of P53

The Board of Regents of the University of Texas System Β· Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7854932

Immunogenic compositions comprising progastrin and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7847084

VMP-like sequences of pathogenic Borrelia species and strains

The Board of Regents of the University of Texas System Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7838556

Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligan

The Board of Regents of the University of Texas System Β· Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7838691

Palmerolides: methods of preparation and derivatives thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7838511

Compositions and methods for treating, preventing and/or ameliorating cancers, the onset o

The Board of Regents of the University of Texas System Β· Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7829668

Compositions and methods for modifying toxic effects of proteinaceous compounds

The Board of Regents of the University of Texas System Β· Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7829688

Peptides of CaV2.2 that inhibit pain

The Board of Regents of the University of Texas System Β· Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7824697

High concentration baclofen preparations

The Board of Regents of the University of Texas System Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7825269

Ligands for nematode nuclear receptors and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7816324

Composition and method for the treatment of diseases affected by a peptide receptor

The Board of Regents of the University of Texas System Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7816131

Cancer specific promoters

The Board of Regents of the University of Texas System Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7816086

Genes of an otitis media isolate of nontypeable Haemophilus influenzae

The Board of Regents of the University of Oklahoma Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7816538

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7811592

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequen

The Board of Regents of the University of Texas System Β· Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807383

Diagnosing and treating hormone resistant cancers

The Board of Regents of the University of Texas System Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807179

Modified reoviral therapy

The Board of Regents of the University of Texas System Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807346

High-throughput assay for virus entry and drug screening

The Board of Regents of the University of Texas System Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted